Literature DB >> 12171923

Induction of terminal differentiation by the c-Jun dimerization protein JDP2 in C2 myoblasts and rhabdomyosarcoma cells.

Olga Ostrovsky1, Eyal Bengal, Ami Aronheim.   

Abstract

Muscle cell differentiation is a result of a complex interplay between transcription factors and cell signaling proteins. Proliferating myoblasts must exit from the cell cycle prior to their differentiation. The muscle regulatory factor and myocyte enhancer factor-2 protein families play a major role in promoting muscle cell differentiation. Conversely, members of the AP-1 family of transcription factors that promote cell proliferation antagonize muscle cell differentiation. Here we tested the role of the c-Jun dimerization protein JDP2 in muscle cell differentiation. Endogenous expression of JDP2 was induced in both C2C12 myoblast and rhabdomyosarcoma (RD) cells programmed to differentiate. Ectopic expression of JDP2 in C2C12 myoblast cells inhibited cell cycle progression and induced spontaneous muscle cell differentiation. Likewise, constitutive expression of JDP2 in RD cells reduced their tumorigenic characteristics and restored their ability to differentiate into myotubes. JDP2 potentiated and synergized with 12-O-tetradecanoylphorbol-13-acetate to induce muscle cell differentiation of RD cells. In addition, JDP2 induced p38 activity in both C2 and RD cells programmed to differentiate. This is the first demonstration of a single transcription factor that rescues the myogenic program in an otherwise non-differentiating cancer cell line. Our results indicate that the JDP2 protein plays a major role in promoting skeletal muscle differentiation via its involvement in cell cycle arrest and activation of the myogenic program.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12171923     DOI: 10.1074/jbc.M205494200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  29 in total

1.  JDP2 inhibits the epithelial-to-mesenchymal transition in pancreatic cancer BxPC3 cells.

Authors:  Zhe Liu; Ruixia Du; Jin Long; Anbing Dong; Jianpeng Fan; Kejian Guo; Yuanhong Xu
Journal:  Tumour Biol       Date:  2012-04-27

2.  TGFbeta1 regulation of vimentin gene expression during differentiation of the C2C12 skeletal myogenic cell line requires Smads, AP-1 and Sp1 family members.

Authors:  Yongzhong Wu; Xueping Zhang; Morgan Salmon; Xia Lin; Zendra E Zehner
Journal:  Biochim Biophys Acta       Date:  2006-12-06

3.  The AP-1 repressor protein, JDP2, potentiates hepatocellular carcinoma in mice.

Authors:  Keren Bitton-Worms; Eli Pikarsky; Ami Aronheim
Journal:  Mol Cancer       Date:  2010-03-09       Impact factor: 27.401

4.  Comparison of genome-wide binding of MyoD in normal human myogenic cells and rhabdomyosarcomas identifies regional and local suppression of promyogenic transcription factors.

Authors:  Kyle L MacQuarrie; Zizhen Yao; Abraham P Fong; Scott J Diede; Erin R Rudzinski; Douglas S Hawkins; Stephen J Tapscott
Journal:  Mol Cell Biol       Date:  2012-12-10       Impact factor: 4.272

5.  Over-expression of the transcription factor, ZBP-89, leads to enhancement of the C2C12 myogenic program.

Authors:  Morgan Salmon; Gary K Owens; Zendra E Zehner
Journal:  Biochim Biophys Acta       Date:  2009-02-14

6.  JDP2 (Jun Dimerization Protein 2)-deficient mouse embryonic fibroblasts are resistant to replicative senescence.

Authors:  Koji Nakade; Jianzhi Pan; Takahito Yamasaki; Takehide Murata; Bohdan Wasylyk; Kazunari K Yokoyama
Journal:  J Biol Chem       Date:  2009-02-20       Impact factor: 5.157

Review 7.  Maternal obesity, inflammation, and fetal skeletal muscle development.

Authors:  Min Du; Xu Yan; Jun F Tong; Junxing Zhao; Mei J Zhu
Journal:  Biol Reprod       Date:  2009-06-10       Impact factor: 4.285

8.  Differential targeting of the stress mitogen-activated protein kinases to the c-Jun dimerization protein 2.

Authors:  Sigal Katz; Ami Aronheim
Journal:  Biochem J       Date:  2002-12-15       Impact factor: 3.857

9.  The ubiquitously expressed bZIP inhibitor, JDP2, suppresses the transcription of its homologue immediate early gene counterpart, ATF3.

Authors:  Keren Weidenfeld-Baranboim; Tal Hasin; Ilona Darlyuk; Ronit Heinrich; Ofer Elhanani; Jianzhi Pan; Kazunari K Yokoyama; Ami Aronheim
Journal:  Nucleic Acids Res       Date:  2009-02-20       Impact factor: 16.971

10.  Activation of alternative Jdp2 promoters and functional protein isoforms in T-cell lymphomas by retroviral insertion mutagenesis.

Authors:  Mads Heilskov Rasmussen; Bruce Wang; Matthias Wabl; Anders Lade Nielsen; Finn Skou Pedersen
Journal:  Nucleic Acids Res       Date:  2009-06-05       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.